The most frequent reason for prescribing TTR gene analysis was orthostatic hypotension (69%) (Table 2) while the most common reasons for not offering a TTR test were an alternative diagnosis (41%) or a lack of knowledge about the differential diagnosis of CIDP (41%) (Table 3). The gene discussed is TTR; the disease is hypotensive disorder.